|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE|
|Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi|
|Clin Mol Hepatol. 2017;23(1):42-50. Published online 2017 March 7 DOI: https://doi.org/10.3350/cmh.2016.0058|
A Role of Scheduled Second Tace in Early Stage Hepatocellular Carcinoma Showing Complete Response After the First Tace
The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?
Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
Transcathether arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Report on TACE-related glucose metabolism impairement and survival
INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE?
788 INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE?
TACE it or leave it: hard choices for intermediate-stage hepatocellular carcinoma patients beyond perfect health
Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma
THU-11 Hepatocellular carcinoma – Intraarterial therapies: SIRT or TACE
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|